Symptomatic drugs, are effective and may reduce the severity of your allergy symptoms, though these medications have no long-lasting effect when stopped. 1,2
Allergy immunotherapy (AIT) is considered to be the only potentially causal therapy for allergic diseases and consists of administering gradually increasing doses of the triggering allergen(s) until the immune system, over time, builds tolerance to that allergen. Allergy immunotherapy can improve allergy symptoms, reduce the use of symptomatic medications and may provide long-lasting persistent effects on your allergy symptoms. 1,2,3,4,5
Once the triggering allergens are correctly identified, avoiding or minimising your exposure to these, may help reduce your symptoms, whenever this is possible.
1. www.allergyuk.org (last accessed on May 11, 2016).
2. Bousquet J, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008. Allergy 2008;63(S86):8-160.
3. Canonica GW, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J 2014;7:6.
4. Jutel M et al. International consensus on allergy immunotherapy J Allergy Clin Immunol 2015 Sep;136(3):556-68.
5. Jutel M et al. International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol 2016 Feb;137(2):358-68.
6. Calderon et al. EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clinical and Translational Allergy 2012, 2:20.
7. www.eaaci.org/patients/ (last accessed on May 11, 2016).